Blog | HemaCare

Engineering Hematopoietic Stem Cells for a One-Two Punch of Cancer Immunotherapy

Mar 26, 2014 6:16:13 AM / by Maria posted in PBCs, cancer, Cancer Immunology, cancer immunotherapy, cell therapy, chemotherapy, drug development, hematopoietic stem cells, HSCs, immunotherapy, Innovation, leukemia, lymphoma, Peripheral blood cells, research, stem cell therapy, stem cells, T cells

0 Comments

In Part I of this series we introduced T cell based immunotherapy and in Part II we discussed how chimeric antigen receptors (CARs) expressing T cells can be even more potent. In Part III below, we expand this concept further by covering hematopoetic stem cells and additional ways they can be engineered for promising immunotherapy of cancer and leukemia.

Read More

Will T Cells Be the Future Basis of Cancer Therapy?

Mar 12, 2014 6:00:07 AM / by Maria posted in PBCs, antibodies, Bone marrow, cancer, Cancer Immunology, cell therapy, chemotherapy, cord blood, drug development, Innovation, Peripheral blood cells, peripheral blood mononuclear cells, research, stem cell therapy, stem cells, T cells, T lymphocytes, tumor

0 Comments

Recent data suggest that the average person has about a 40% chance of developing cancer at some point in his or her lifetime. [1] If those statistics are not frightening enough, let’s talk treatment: chemotherapy, radiation, surgery, chemical-based drug therapy, or a combination of the above. And don’t forget the various side effects of cancer therapy, many of which are a result of the destruction of crucial adult stem cells in the body. Because of this, stem cell transplants have been performed with fresh stem cells originating from bone marrow, peripheral blood, or cord blood to help replenish a patient’s hematopoietic system.

Read More

Revolutionizing Drug Discovery with Mass-Tag Cellular Barcoding and PBMCs

Feb 6, 2014 12:00:09 PM / by Maria posted in drug screening, PBCs, antibodies, drug development, drug discovery, Innovation, mass cytometry, mass-tag cellular barcoding, MCB, Peripheral blood cells, peripheral blood mononuclear cells, phosphorylation, research

0 Comments

Using peripheral blood mononuclear cells (PBMCs) with a new technique called mass-tag cellular barcoding (MCB) may change the drug discovery game as we know it.

Read More

Peripheral Blood Mononuclear Cells (PBMCs) in Cancer Drug Discovery and Development

Jan 30, 2014 3:00:06 PM / by Maria posted in drug screening, PBCs, aging, cancer, cancer drug assay, chemotherapy, drug development, drug discovery, Innovation, PBMCs, Peripheral blood cells, peripheral blood mononuclear cells, research, tumor

0 Comments

In Part II of this series we discussed how peripheral blood mononuclear cells can be used to screen for drugs responses in healthy and infected cells. Here we discuss other measurements that are particularly useful in the context of cancer drug discovery and development.

Read More

Drug Screening in Healthy and Diseased PBMCs

Jan 22, 2014 2:32:37 PM / by Maria posted in drug screening, PBCs, proliferation, apoptosis, drug development, drug discovery, infection, inflammation, Innovation, migration, PBMCs, Peripheral blood cells, peripheral blood mononuclear cells, research, viability

0 Comments

Peripheral Blood Mononuclear Cells (PBMCs) can be used in drug screening.  In Part I from this series, we discussed how they can be used to assay drug activity including effects on proliferation, viability, apoptosis, inflammation, and migration in healthy and disease cell models.  There are related assays available to measure the effects of drug treatment and, especially for researchers that prefer to use human samples, peripheral blood mononuclear cells are often the cells of choice (PBMCs) are often the cells of choice.  The advantages of using human cells initially are immense.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts